CoChat

Genome-wide association study and targeted metabolomics identifies sex-specific association of CPS1 with coronary artery disease

Open access

The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.

Abstract

Metabolites derived from dietary choline and L-carnitine, such as trimethylamine N-oxide and betaine, have recently been identified as novel risk factors for atherosclerosis in mice and humans. We sought to identify genetic factors associated with plasma betaine levels and determine their effect on risk of coronary artery disease (CAD). A two-stage genome-wide association study (GWAS) identified two significantly associated loci on chromosomes 2q34 and 5q14.1. The lead variant on 2q24 (rs715) localizes to carbamoyl-phosphate synthase 1 (CPS1), which encodes a mitochondrial enzyme that catalyses the first committed reaction and rate-limiting step in the urea cycle. Rs715 is also significantly associated with decreased levels of urea cycle metabolites and increased plasma glycine levels. Notably, rs715 yield a strikingly significant and protective association with decreased risk of CAD in only women. These results suggest that glycine metabolism and/or the urea cycle represent potentially novel sex-specific mechanisms for the development of atherosclerosis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/ncomms10558

Cites

54 of 54 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Results of a GWAS for plasma betaine levels in the GeneBank cohort. The Manhattan plot for plasma betaine levels shows four significantly or suggestively associated loci on chromosomes 1q32.2, 2q34 5q14.1 and 16q24.1. The symbols for the genes closest to the lead SNPs are shown in italics and genome-wide thresholds for significant (P=5.0 × 10−8) and suggestive (P=5.0 × 10−6) association are indicated by the horizontal red and blue lines, respectively. P-values were obtained using linear regression with natural log transformed values and adjustment for age and sex.
Figure 1 Results of a GWAS for plasma betaine levels in the GeneBank cohort. The Manhattan plot for plasma betaine levels shows four significantly or suggestively associated loci on chromosomes 1q32.2, 2q34 5q14.1 and 16q24.1. The symbols for the genes closest to the lead SNPs are shown in italics and genome-wide thresholds for significant (P=5.0 × 10−8) and suggestive (P=5.0 × 10−6) association are indicated by the horizontal red and blue lines, respectively. P-values were obtained using linear regression with natural log transformed values and adjustment for age and sex.CC BY · PubMed Central
Figure 2 Regional plots for the loci associated with plasma betaine levels. The regions shown for chromosomes 5q14.1 (a) and 2q34 (b) are centred on the lead SNP (purple diamond) for each respective locus. The degree of LD (r2) between the lead SNP and other variants in the selected interval is given according the colour-coded legend in the box and genes are indicated in the bottom panel. Rs1047891 was formerly designated as rs7422339.
Figure 2 Regional plots for the loci associated with plasma betaine levels. The regions shown for chromosomes 5q14.1 (a) and 2q34 (b) are centred on the lead SNP (purple diamond) for each respective locus. The degree of LD (r2) between the lead SNP and other variants in the selected interval is given according the colour-coded legend in the box and genes are indicated in the bottom panel. Rs1047891 was formerly designated as rs7422339.CC BY · PubMed Central
Figure 3 The genes and intermediates of the pathway linking choline metabolism to the urea cycle. One route (green arrows) for the initial catabolism of choline is mediated by intestinal microbes and leads to the formation of trimethylamine (TMA). TMA is efficiently absorbed from the gastrointestinal tract and subsequently oxidized by the liver to form trimethylamine N-oxide (TMAO) through reactions catalysed by one or more of the flavin monooxygenase (FMO) family of enzymes. Alternatively (red arrows), choline can be oxidized to betaine through reactions catalysed by choline dehydrogenase (CHDH) and betaine aldehyde dehydrogenase (ALDH7A1). Betaine (also known as trimethylglycine) is demethylated to form dimethylglycine via the betaine-homocysteine S-methyltransferase enzymes (BHMT, BHMT2). This reaction simultaneously converts homocysteine to methionine. Dimethylglycine dehydrogenase (DMGDH) subsequently demethylates dimethylglycine to form sarcosine, which is then converted to glycine by sarcosine dehydrogenase (SDH) after removal of the remaining methyl group. Glycine is metabolized by a group of enzymes known as the glycine cleavage complex (GCC), which is the major route in animals for glycine degradation and the formation of ammonia (NH3) and carbon dioxide (CO2). NH3 is converted to carbamoyl phosphate, which enters the urea cycle (blue arrows) through the rate-limiting reaction catalysed by carbamoyl-phosphate synthase 1 (CPS1), or can be converted back to glycine through the GCC. Carbamoyl phosphate is metabolized by ornithine transcarbamylase (OTC) to form citrulline and subsequently argininosuccinate through a reaction catalysed by argininosuccinate synthetase (ASS). This is followed by the formation of L-arginine by arginosuccinate lyase (ASL). L-Arginine is used as a substrate for the production of nitric oxide or metabolized by arginase (ARG1) to form urea for excretion and ornithine for re-entry back into the cycle. Metabolites that were available for analysis are shown in black, whereas unmeasured metabolites are shown in grey.
Figure 3 The genes and intermediates of the pathway linking choline metabolism to the urea cycle. One route (green arrows) for the initial catabolism of choline is mediated by intestinal microbes and leads to the formation of trimethylamine (TMA). TMA is efficiently absorbed from the gastrointestinal tract and subsequently oxidized by the liver to form trimethylamine N-oxide (TMAO) through reactions catalysed by one or more of the flavin monooxygenase (FMO) family of enzymes. Alternatively (red arrows), choline can be oxidized to betaine through reactions catalysed by choline dehydrogenase (CHDH) and betaine aldehyde dehydrogenase (ALDH7A1). Betaine (also known as trimethylglycine) is demethylated to form dimethylglycine via the betaine-homocysteine S-methyltransferase enzymes (BHMT, BHMT2). This reaction simultaneously converts homocysteine to methionine. Dimethylglycine dehydrogenase (DMGDH) subsequently demethylates dimethylglycine to form sarcosine, which is then converted to glycine by sarcosine dehydrogenase (SDH) after removal of the remaining methyl group. Glycine is metabolized by a group of enzymes known as the glycine cleavage complex (GCC), which is the major route in animals for glycine degradation and the formation of ammonia (NH3) and carbon dioxide (CO2). NH3 is converted to carbamoyl phosphate, which enters the urea cycle (blue arrows) through the rate-limiting reaction catalysed by carbamoyl-phosphate synthase 1 (CPS1), or can be converted back to glycine through the GCC. Carbamoyl phosphate is metabolized by ornithine transcarbamylase (OTC) to form citrulline and subsequently argininosuccinate through a reaction catalysed by argininosuccinate synthetase (ASS). This is followed by the formation of L-arginine by arginosuccinate lyase (ASL). L-Arginine is used as a substrate for the production of nitric oxide or metabolized by arginase (ARG1) to form urea for excretion and ornithine for re-entry back into the cycle. Metabolites that were available for analysis are shown in black, whereas unmeasured metabolites are shown in grey.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 54 references

Cited by

See all 130

Metadata

Authors
Hartiala, J. A., Wilson Tang, W. H., Wang, Z., Crow, A. L., Stewart, A. F. R., Roberts, R., McPherson, R., Erdmann, J., Willenborg, C., Hazen, S. L., & Allayee, H.
Affiliations
  • University of Southern California (US)
  • Cleveland Clinic (US)
  • Ottawa Heart Institute (CA)
  • Institute for Integrative and Experimental Genomics (DE)
Corresponding author
Allayee, Hooman
Venue
Nature Communications
Published
2016-01-29
Volume
7
Issue
1
Pages
10558-10558
ISSN
2041-1723 (ISSN-L)
OpenAlex
W2299824834
Cited by
130
References
54
Citations by year
2026: 7 · 2025: 13 · 2024: 6 · 2023: 9 · 2022: 15 · 2021: 15 · 2020: 12 · 2019: 18 · 2018: 16 · 2017: 13 · 2016: 6
FWCI
14.26
Type
journal article
Language
en
Open access
Licence
Locations
  • Nature Communications (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • UA Campus Repository (The University of Arizona) (acceptedVersion, cc-by)
  • RePEc: Research Papers in Economics (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • American Heart Association (12SDG12050473)
  • Cleveland Clinic
  • Fondation Leducq
  • National Institutes of Health
  • Canadian Institutes of Health Research (MOT82810)
  • National Heart, Lung, and Blood Institute (R01HL103931, P20HL113452, P01HL076491, P01HL098055, R01HL103866)
  • National Institute of Environmental Health Sciences (R01ES025786, R01ES021801, P30ES007048)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolomics and Mass Spectrometry Studies
Keywords
coronary artery disease, CPS1, sex differences, atherosclerosis, betaine, urea cycle, glycine metabolism, trimethylamine N-oxide, L-carnitine, choline metabolites, plasma metabolites, genetic susceptibility loci
MeSH terms
Betaine, Carbamoyl-Phosphate Synthase (Ammonia), Coronary Disease, Female, Genotype, Humans, Male, Sex Factors, Gene Expression Regulation, Enzymologic, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide, Genome-Wide Association Study, Metabolomics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.